肿瘤治疗所致血小板减少症相关巨核细胞分化发育异常及中医药干预策略的研究进展
鲁佳慧 1,2,3,陈猛 1,2,张莹 1,2 *
作者信息
- 1 天津中医药大学第一附属医院,天津 300381
- 2 中医国家临床医学研究中心,天津 300381
- 3 天津中医药大学,天津 301617
*通信作者
摘要
肿瘤治疗所致血小板减少症(CTIT)是抗肿瘤治疗常见的血液学不良反应,其发生与造血干祖细胞(HSPCs)损伤、巨核细胞(MK)分化成熟障碍、骨髓生态位破坏及外周免疫性血小板清除等多环节异常有关。不同治疗方式可作用于血小板生成的不同阶段:化疗主要通过耗竭 HSPCs、抑制血小板生成素 (TPO)-Janus 激酶 2(JAK2)/信号转导及转录激活因子 3( STAT3)信号通路及破坏骨髓血管龛影响 MK的增殖与成熟;放疗则通过诱导脱氧核糖核酸(DNA)损伤、氧化应激和内皮功能障碍,削弱造血系统的重建能力;部分靶向药物及抗肿瘤药物还可通过抑制巨核生成相关激酶或诱导药物依赖性抗体,加重血小板生成不足或外周清除增加。骨髓、脾脏和肺构成的多器官巨核生成网络,为认识 CTIT 提供了整体视角。中医药具有多成分、多靶点优势,可通过调控 GATA 结合蛋白1/2(GATA1 / 2)、磷脂酰肌醇 3-激酶/ 蛋白激酶 B(PI3K/AKT)、丝裂原活化蛋白激酶/细胞外信号调节激酶(MAPK/ERK)以及JAK/ STAT 等信号通路,促进造血恢复、MK 分化成熟及血小板生成。综述 CTIT 相关 MK分化异常、多器官生态位损伤及中医药干预策略,为分层防治和转化研究提供参考。
Research progress on abnormal megakaryocyte differentiation and development associated with cancer treatment -induced thrombocytopenia and TCM intervention strategies
Jiahui LU 1,2,3, Meng CHEN 1,2, Ying ZHANG 1,2 *
Author Information
- 1 First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China
- 2 National Clinical Research Center for Chinese Medicine, Tianjin 300381, China
- 3 Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
*Corresponding author
Abstract
Cancer treatment-induced thrombocytopenia (CTIT) is a common hematological adverse event during antitumor therapy. Its development is associated with abnormalities at multiple levels, including damage to hematopoietic stem and progenitor cells (HSPCs), impaired megakaryocyte (MK) differentiation and maturation, disruption of the bone marrow niche, and immune-mediated peripheral platelet clearance. Different therapeutic modalities affect distinct stages of platelet production. Chemotherapy mainly impairs MK proliferation and maturation by depleting hematopoietic progenitors, inhibiting the thrombopoietin (TPO)-Janus kinase 2/ signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway, and disrupting the bone marrow vascular niche. Radiotherapy compromises hematopoietic reconstitution through DNA damage, oxidative stress, and endothelial dysfunction. In addition,some targeted agents and antitumor drugs may aggravate insufficient platelet production or enhanced peripheral platelet clearance by inhibiting kinases involved in megakaryopoiesis or inducing drug-dependent antibodies.The bone marrow,spleen,and lung together constitute a multi-organ megakaryopoiesis network, providing an integrated perspective for understanding CTIT. Traditional Chinese medicine, characterized by multi-component and multi-target regulatory effects, may modulate pathways such as GATA binding protein 1/2 (GATA1/2), phosphatidylinositol-3 kinase/protein kinase B (PI3K/AKT),mitogen-activated protein kinases/ extracellular regulated protein kinases (MAPK/ERK), and JAK/STAT, thereby promoting hematopoietic recovery, MK differentiation and maturation, and platelet production. This review summarizes MK differentiation abnormalities,multi-organ niche injury, and traditional Chinese medicine intervention strategies associated with CTIT, aiming to provide a reference for stratified prevention and treatment as well as translational research.
